{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:26:15Z","timestamp":1790717175537,"version":"4.1.0"},"reference-count":0,"publisher":"American Psychological Association (APA)","issue":"6","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"am","delay-in-days":292,"URL":"http:\/\/www.apa.org\/pubs\/journals\/resources\/open-access.aspx"}],"funder":[{"name":"MyMD Pharmaceuticals, Inc."},{"name":"MIRA-1 Pharmaceuticals, Inc."},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA015971"],"award-info":[{"award-number":["R01AA015971"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clearmind Medicine, Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental and Clinical Psychopharmacology"],"DOI":"10.1037\/pha0000741","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T13:58:51Z","timestamp":1726754331000},"page":"625-638","source":"Crossref","is-referenced-by-count":6,"title":["Oxytocin as a treatment for alcohol use disorder and heavy drinking: A narrative review."],"prefix":"10.1037","volume":"32","author":[{"given":"Kriti","family":"Rastogi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8234-0919","authenticated-orcid":false,"given":"Elise M.","family":"Weerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8156-6772","authenticated-orcid":false,"given":"Jennifer D.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"15","published-online":{"date-parts":[[2024,12]]},"container-title":["Experimental and Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/psycnet.apa.org\/journals\/pha\/32\/6\/625.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T14:16:48Z","timestamp":1737037008000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.apa.org\/doi\/10.1037\/pha0000741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":0,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2025-26462-001","39298263"],"URL":"https:\/\/doi.org\/10.1037\/pha0000741","relation":{},"ISSN":["1936-2293","1064-1297"],"issn-type":[{"value":"1936-2293","type":"electronic"},{"value":"1064-1297","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}